"These men are aware that once they start drug therapy, they can never stop," noted Ron Stall, who presented the findings in Geneva. "Someone not prepared to make that commitment is better off delaying therapy than following it inconsistently, possibly creating resistant strains. From an adherence standpoint, it is probably better if someone who's not sure waits to begin therapy."
Even so, the two-year old International AIDS Society-USA-continues to advocate early and potent combination therapies. Their revised recommendations--announced in Geneva last week and published in the July 1 issue of the Journal of the American Medical Association--hail HAART as the best hope against AIDS, at least for now.